Alan Collis

523 total citations
13 papers, 254 citations indexed

About

Alan Collis is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Alan Collis has authored 13 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Alan Collis's work include Melanoma and MAPK Pathways (4 papers), Computational Drug Discovery Methods (3 papers) and Synthesis and Catalytic Reactions (3 papers). Alan Collis is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Computational Drug Discovery Methods (3 papers) and Synthesis and Catalytic Reactions (3 papers). Alan Collis collaborates with scholars based in United Kingdom, United States and Switzerland. Alan Collis's co-authors include Iain Coldham, John E. Souness, Iain M. McLay, Frank Halley, Stephen D. Pickett, Giorgio Ottaviani, Giuliano Berellini, Peter Ertl, Bernard Faller and Jeffrey M. McKenna and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Alan Collis

12 papers receiving 240 citations

Peers

Alan Collis
Lianyun Zhao United States
James E. H. Day United Kingdom
Michael Reader United Kingdom
Felix González-López de Turiso United States
Deborah A. Mischke United States
Brian R. Lahue United States
Shuaige Wang United States
Anke Mueller‐Fahrnow France
Divya Pingili India
Aijun Lu China
Lianyun Zhao United States
Alan Collis
Citations per year, relative to Alan Collis Alan Collis (= 1×) peers Lianyun Zhao

Countries citing papers authored by Alan Collis

Since Specialization
Citations

This map shows the geographic impact of Alan Collis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Collis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Collis more than expected).

Fields of papers citing papers by Alan Collis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Collis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Collis. The network helps show where Alan Collis may publish in the future.

Co-authorship network of co-authors of Alan Collis

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Collis. A scholar is included among the top collaborators of Alan Collis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Collis. Alan Collis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2021). Abstract 1649: Mechanistic understanding of HPK1 inhibition on enhanced human T cell activation and tumor immunity in a syngeneic model. Cancer Research. 81(13_Supplement). 1649–1649. 1 indexed citations
2.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2020). 685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. SHILAP Revista de lepidopterología. A411.1–A411. 1 indexed citations
3.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2020). A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. European Journal of Cancer. 138. S20–S20. 1 indexed citations
4.
Ciccone, David, Jennifer L. Rocnik, Ian D. Linney, et al.. (2020). Abstract 942: HPK1, hematopoietic progenitor kinase 1, is a promising therapeutic target for cancer immunotherapy. Cancer Research. 80(16_Supplement). 942–942.
5.
Martin, Matthew W., Jennifer Y. Lee, David R. Lancia, et al.. (2018). Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11. Bioorganic & Medicinal Chemistry Letters. 28(12). 2143–2147. 41 indexed citations
6.
Faller, Bernard, Giorgio Ottaviani, Peter Ertl, Giuliano Berellini, & Alan Collis. (2011). Evolution of the physicochemical properties of marketed drugs: can history foretell the future?. Drug Discovery Today. 16(21-22). 976–984. 35 indexed citations
7.
Mondal, Milon, Joseph Gabriels, Maria Chiara Magnifico, et al.. (2010). High-Content Micronucleus Assay in Genotoxicity Profiling: Initial-Stage Development and Some Applications in the Investigative/Lead-Finding Studies in Drug Discovery. Toxicological Sciences. 118(1). 71–85. 8 indexed citations
8.
McKenna, Jeffrey M., Frank Halley, John E. Souness, et al.. (2002). An Algorithm-Directed Two-Component Library Synthesized Via Solid-Phase Methodology Yielding Potent and Orally Bioavailable p38 MAP Kinase Inhibitors. Journal of Medicinal Chemistry. 45(11). 2173–2184. 53 indexed citations
9.
Collis, Alan, Martyn Foster, Frank Halley, et al.. (2001). RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency. Bioorganic & Medicinal Chemistry Letters. 11(5). 693–696. 33 indexed citations
10.
Coldham, Iain, et al.. (1995). Synthesis of 4-phenylpiperidines by tandem Wittig olefination–aza-Wittig rearrangement of 2-benzoylaziridines. Journal of the Chemical Society Perkin Transactions 1. 2739–2745. 23 indexed citations
11.
Kenny, Barry, Alan Collis, A.M. Naylor, & Michael G. Wyllie. (1995). Section Review Central & Peripheral Nervous Systems: α1-Adrenoceptor antagonists as treatments for benign prostatic hyperplasia. Expert Opinion on Investigational Drugs. 4(10). 915–923. 7 indexed citations
12.
Coldham, Iain, et al.. (1995). Ring expansion of aziridines to piperidines using the aza-wittig rearrangement. Tetrahedron Letters. 36(20). 3557–3560. 33 indexed citations
13.
Coldham, Iain, et al.. (1995). Pyrrolidines by 1,3-Dipolar Cycloaddition of Conjugated Azomethine Ylides. Synthesis. 1995(9). 1147–1150. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianyun Zhao Breakdown of academic impact, for papers by James E. H. Day Breakdown of academic impact, for papers by Michael Reader Breakdown of academic impact, for papers by Felix González-López de Turiso Breakdown of academic impact, for papers by Deborah A. Mischke Breakdown of academic impact, for papers by Brian R. Lahue Breakdown of academic impact, for papers by Shuaige Wang Breakdown of academic impact, for papers by Anke Mueller‐Fahrnow Breakdown of academic impact, for papers by Divya Pingili Breakdown of academic impact, for papers by Aijun Lu
Rankless by CCL
2026